Garden Biopharmaceutical Reports 1.29% Decline in Vitamin D3 Revenue for H1 2024, with a Gross Margin of 54.86%
Continue reading with Effamall membership.
Already a member? Login here.
Tag:
Copy Link
<Prev
Next>
<Prev
Next>
